Q4 2024 Holdings
Filed 2025-02-14 | 6 holdings | $124.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $75.7M | 4,381,062 | 60.9% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $21.0M | 2,738,785 | 16.9% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $16.1M | 682,376 | 12.9% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $6.3M | 4,284,172 | 5.1% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $3.0M | 5,555,461 | 2.4% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $2.2M | 1,683,707 | 1.8% |